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Abstract: Coffee has been associated with reductions in the risk of non-communicable 
chronic diseases (NCCD), including diabetes mellitus. Because differences in food habits 
are  recognizable  modifying  factors  in  the  epidemiology  of  diabetes,  we  studied  the 
association of coffee consumption with type-2 diabetes in a sample of the adult population 
of  the  Federal  District,  Brazil.  This  cross-sectional  study  was  conducted  by  telephone 
interview (n = 1,440). A multivariate analysis was run controlling for socio-behavioural 
variables, obesity and family antecedents of NCCD. A hierarchical linear regression model 
and a Poisson regression were used to verify association of type-2 diabetes and coffee 
intake.  The  independent  variables  which  remained  in  the  final  model,  following  the 
hierarchical  inclusion  levels,  were:  first  level—age  and  marital  status;  second  
level—diabetes  and  dyslipidaemias  in  antecedents;  third  level—cigarette  smoking, 
supplement intake, body mass index; and fourth level—coffee intake (≤100 mL/d, 101 to 
400  mL/day,  and  >400  mL/day).  After  adjusting  hierarchically  for  the  confounding 
variables,  consumers  of  100  to  400  mL  of  coffee/day  had  a  2.7%  higher  (p  =  0.04) 
prevalence of not having diabetes than those who drank less than 100 mL of coffee/day. 
Compared to coffee intake of ≤100 mL/day, adults consuming >400 mL of coffee/day 
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showed no statistically significant difference in the prevalence of diabetes. Thus, moderate 
coffee  intake  is  favourably  associated  with  self-reported  type-2  diabetes  in  the  studied 
population.  This  is  the  first  study  to  show  a  relationship  between  coffee  drinking  and 
diabetes in a Brazilian population. 
Keywords: coffee intake; diabetes mellitus; chlorogenic acids; caffeine; body mass index 
 
1. Introduction 
Coffee is one of the most widely consumed beverages in the Western world. Therefore, concerns 
about  health  risks  and  benefits  associated  with  coffee  (and  attendant  caffeine  intake)  shown  by 
epidemiological  studies  are  likely  to  be  influenced  by  social  and  metabolic  profiles  of  studied 
populations. Coffee, in its beverage form, is a complex chemical mixture, especially after the roasting 
process [1]; however, because it is rich in antioxidants and nutrients it generally seems to be associated 
with a healthy profile in consumers, and studies have shown that coffee can be considered a functional 
food [2]. Indeed, regular coffee drinking (depending on the quantity consumed) can directly affect the 
intake of micronutrients (K, Mg, Mn, Cr, niacin) and antioxidant substances. It has also shown positive 
effects  on  various  aspects  of  health,  such  as  neurological  (infant  hyperactivity,  Alzheimer’s  and 
Parkinson’s  diseases)  and  metabolic  disorders  (diabetes  mellitus,  gallstones,  liver  cirrhosis),  and 
gonadal and liver function [2]. 
Although coffee is a beverage rich in antioxidants, it is also rich in caffeine, which is the most 
studied  compound  of  coffee.  This  methylxanthine  increases  attention  and  alertness  levels,  and 
improves work performance and readiness for physical activity [3]. However, caffeine may also impair 
insulin sensitivity and glucose tolerance [4,5]. 
The epidemiology of diabetes mellitus has increased substantially in developed countries and is 
now also becoming a major problem in developing countries [6]. Indeed, the epidemiology of diabetes 
mellitus in Brazil has substantially changed in the last decade [7,8], and projections for 2030 suggest 
that  11.3  million  people  will  be  affected  [7].  The metabolism  underlying  type-2  diabetes  poses  a 
greater risk for hypertension, dyslipidaemia, and cardiovascular diseases; therefore, diet and nutrition 
are  central  to  controlling  and  preventing  NCCD  [6].  Because  coffee  drinking  impacts  a  broad 
demographic, earlier findings that it might be associated with NCCD such as diabetes mellitus have 
raised interest in epidemiological studies in Eastern and Western industrialized countries. Thus, both 
prospective  [9-13]  and  cross-sectional  [14,15]  studies  indicate  a  decreased  risk  of  type-2  diabetes 
associated with coffee drinking. 
The  factors  associated  with  coffee  intake  and  risk  of  type-2  diabetes  are  likely  to  depend  on 
variables not only intrinsically related to coffee preparation and consumption [16,17],
 but also to other 
environmental and dietary variables [14,18,19], such as smoking, sedentarism and poor diet. Thus, we 
sought to evaluate the association of coffee consumption and self-reported type-2 diabetes in a sample 
of urban adults living in the Federal District, Brazil. Int. J. Environ. Res. Public Health 2011, 8                 
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2. Experimental Section 
The Federal District of Brazil consists of the country’s capital (Brasília) and several other satellite 
towns and communities covering an area of 5,801.9 km
2 and with a population of 2.3 million people. 
We  designed  a  cross-sectional  population-based  survey  with  adult  subjects  living  in  the  Federal 
District. The study was conducted through a simple-standardized questionnaire validated in a pilot 
study performed before the research began. The questionnaire was based on the Behavioral Risk Factor 
Surveillance  System  (BRFSS)  [20],  which  has  been  previously  validated  [21].  Through  telephone 
interview  we  collected  information  on  detailed  coffee  intake,  socio-behavioural  aspects,  years  of 
schooling, physical activity, cigarette smoking, alcohol intake, self-reported weight and height, use of 
nutritional supplements, and family and personal history of NCCD. Self-reported weight and height 
have  been  previously  validated  in  Brazil  [22,23]  The  questions  used  to  assess  diabetes  mellitus 
presence, according to the BRFSS [20] were: “Did your doctor say that you have diabetes?” and 
“What  is  the  name  of  the  medicine  you  take  to  control  diabetes?”  If  the  interviewed  person  had 
diabetes diagnose, questions were asked to define the diabetes type: “Did your doctor say which type 
of diabetes you have?” and “When your diabetes diagnosis was made how old were you?” and also 
“Do you use insulin injections every day?” 
All questionnaires were reviewed by one of the authors (L.M.); all information collected about other 
NCCDs was obtained by  asking if the person  had received the diagnosis from a doctor or health 
professional.  Inclusion  criteria  were  age  ≥18  years  and  agreement  to  participate  in  the  study.  For 
mobile telephones the owner was contacted and for residential telephones a permanent resident was 
invited to enter the study. In the case of two phone lines for the same address or individual the first 
interview  was  kept,  the  telephone  number  excluded  and  the  following  selected  number  contacted. 
Exclusion criteria included <18 years of age, incomplete data in the questionnaire and any person who 
did  not  agree  with  the  term  of  consent.  When  a  number  was  called  more  than  ten  times  and  we 
received no answer or only a standard recorded message from the phone company, that number was 
excluded. The total number of calls was calculated to be 1,400 following a sampling protocol. 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and 
all procedures involving human subjects were approved by the Research Ethics Committee of the 
University of Brasília Faculty of Health Sciences (020/2006). The participants were properly informed 
of the objectives of the study and oral informed consent was obtained from all of them; consent was 
recorded electronically. 
2.1. Sampling  
The individuals selected for interview were randomly drawn from mobile and residential telephone 
lists. Due to the high cost of mobile telephone calls, we expected that 80% of the sample would be 
from residential numbers. For sample calculation, a coffee intake prevalence of 91% was considered. 
Precision of 1.5% and a significance level of 5% were adopted and a sample of 1,400 subjects was 
obtained.  The  telephone  interview  was  conducted  by  a  team  of  trained  nutrition  students.  The 
interview  was  recorded  electronically  (PCTEL  version  1.0,  Brasília,  Brazil)  and  the  questionnaire 
answers were recorded directly into a computer using Epi Info version 6.04d (CDC, USA).  Int. J. Environ. Res. Public Health 2011, 8                 
 
 
3219
2.2. Statistical Analysis 
SPSS version 13 (for Windows) was used to perform descriptive statistical analyses. The Fisher 
exact test was run to ascertain statistical differences between categorical variables (categories of coffee 
intake with sex, age, years of schooling, marital status, alcohol and supplement use, cigarette smoking, 
physical  activity  practised,  family  disease  history).  The  Poisson  regression  model  was  employed 
because the outcome variable (type-2 diabetes status; yes, 4% and no 96% prevalence), is binary, and 
the study is cross-sectional [24]. Sample design was robust to reach people from all regions of the 
Federal  District.  Percentages  of  population  in  the  main  zones  from  the  census 
(http://www.brasilia.df.gov.br/) and from the sample were, respectively: zone 1, 1.2% and 1.8%; zone 
2, 2.5% and 1.6%; zone 3, 6.5%–5.0%, and zone 4, 13.7% and 12%. Due to the large number of 
women interviewed at the expense of men, sample weighting was performed. The values of variables 
were weighted for sex, age and years of schooling; the weights were determined by the ratio between 
the proportions of the Census from the year 2000 [25] and the sample (Supplemental Data).  
Coffee intake was obtained as a continuous variable (mL/day) and was tested for trend with no 
statistical significance. For this reason coffee intake was categorized and included in the model as a 
categorical variable. We used the STATA (version 10) program to run Poisson regression, using a 
robust variance procedure, in a univariate and a multivariate analysis to obtain prevalence ratios (PR) 
and 95% confidence intervals (95% CI). Multivariate analysis was performed using  a hierarchical 
linear regression model. The variables were introduced according to their causality for type-2 diabetes 
and coffee intake. 
In the multivariate model variables were adjusted to those of the same level (explanatory variables) 
and  higher  levels  (confounders), i.e.,  from  level  one  to  level  four.  Each  variable  block  level  was 
included sequentially and the variables with p ≤ 0.20 in the likelihood ratio test remained in the model. 
The first level of the hierarchical linear regression model was composed of the socio-demographic 
variables: sex, age, years of study and marital status; the second level by history of family chronic 
diseases: hypertension, cancer, Parkinson’s disease, Alzheimer’s disease, diabetes and dyslipidaemias; 
the third level was made up of body mass index (BMI in Kg/m
2) and lifestyle characteristics related to 
cigarette smoking, use of nutritional supplements, physical activity; the fourth level was coffee intake 
volume per day. The dependent variable in the model was self-reported type-2 diabetes (modelled with 
the binary response of higher prevalence—in this case ‘no’ respondents). The independent variables 
which remained in the final model were age (in years), marital status (single, married and other), 
diabetes mellitus and dyslipidaemia antecedents (yes or no), cigarette smoking (smoker, ex-smoker, 
non-smoker), use of supplement (yes or no), body mass index and coffee intake (≤100 mL, 101 to 400 
mL, and more than 400 mL per day). Referent values in each level were arbitrarily established and 
based  on  previously  published  research  [11,17].  Descriptive  values  were  presented  as  raw  values, 
while the results from the hierarchical linear regression model and Poisson regression for the PR were 
presented as weighted values. Int. J. Environ. Res. Public Health 2011, 8                 
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3. Results  
Of the 1,440 interviews, there were 78% (1,126) subjects contacted via residential telephone and 
22% (314) by mobile telephone calls. The interviewed population ranged in age from 18 to 89 years 
and the majority were women (67%). Regarding coffee drinking habits, the vast majority were regular 
consumers (81%) and 65% reported drinking up to 400 mL of coffee per day. Table 1 shows frequency 
of coffee intake as a function of demographic, socio-behavioural, and BMI characteristics. Individuals 
were more likely to drink coffee at an older age and when married; coffee drinkers were also less 
physically active and more were smokers. Among smokers the number of cigarettes was higher in 
heavy coffee drinkers and lower in non-coffee drinkers. Overweight was present in 40% of the subjects 
and  the  overall  mean  BMI  was  24.4  ±  4  kg/m
2.  Among  non-coffee  drinkers  there  were  a  high 
percentage of thin (26%) and normal BMI (21%) subjects. On the other hand, subjects consuming 
>400 mL/day of coffee had high percentages of overweight (19%) and obesity (22%). Sugar was the 
main form of sweetener used (74%) but was not quantified. In many circumstances the amount of 
sugar consumed with coffee is added to large containers (frequently a thermos) for family or general 
consumption. 
Table 1. Population characteristics (socio-behavioural and body mass index) according to 
coffee intake groups from individuals in the Federal District, Brazil, 2006–2009. 
Characteristics 
Coffee intake (mL/d) 
P value 
￿ 
NCC  ≤100  101–400  >400 
Total group (N) 
271  440  491  238 
N  %  N  %  N  %  N  % 
Age (years) 
<30 
30–40 
40–60 
>60 
 
106 
81 
65 
19 
 
26 
20 
15 
11 
 
153 
127 
105 
55 
 
38 
31 
24 
31 
 
108 
143 
171 
68 
 
26 
34 
39 
38 
 
40 
63 
98 
37 
 
10 
15 
22 
21 
 
0.000 
Years of education 
 ≤8 
 8–11 
 11–15 
 15–20  
 
56 
121 
74 
 13 
 
15 
21 
19 
16 
 
116 
187 
111 
22 
 
31 
33 
29 
27 
 
127 
182 
140 
29 
 
34 
32 
36 
35 
 
76 
76 
63 
18 
 
20 
14 
16 
22 
 
 
0.055 
Sex 
 Male 
 Female 
 
94 
177 
 
20 
18 
 
135 
305 
 
29 
32 
 
151 
340 
 
32 
35 
 
91 
147 
 
19 
15 
 
0.143 
Marital status 
 Bachelor 
 Married 
 Divorced 
 Widow 
 Co-habiting 
 
139 
87 
21 
11 
3 
 
25 
14 
19 
15 
7 
 
194 
186 
24 
19 
11 
 
35 
31 
21 
26 
24 
 
163 
214 
42 
32 
17 
 
30 
35 
38 
44 
38 
 
57 
121 
25 
11 
14 
 
10 
20 
22 
15 
31 
 
 
0.000 
Physical activity 
 Practiced 
 Non-practiced 
 
165 
106 
 
22 
15 
 
229 
211 
 
30 
31 
 
245 
246 
 
33 
36 
 
111 
127 
 
15 
18 
 
0.007 Int. J. Environ. Res. Public Health 2011, 8                 
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Table 1. Cont. 
Minutes per week 
 <150 
 150–300 
 >300 
 
28 
63 
70 
 
17 
20 
27 
 
58 
98 
69 
 
34 
32 
27 
 
62 
98 
83 
 
36 
31 
33 
 
22 
52 
35 
 
13 
17 
13 
 
0.120 
Use of supplements 
 Yes 
 No 
 
24 
247 
 
18 
19 
 
41 
399 
 
31 
30 
 
49 
442 
 
38 
34 
 
17 
221 
 
13 
17 
0.674 
Alcohol use 
 Yes 
 No 
 
101 
170 
 
17 
20 
 
190 
250 
 
31 
30 
 
208 
283 
 
34 
34 
 
108 
130 
 
18 
16 
0.270 
Alcohol intake (mL/day) 
 ≤100  
 100–199 
 ≥200  
 
42 
10 
19 
 
16 
11 
18 
 
73 
28 
36 
 
28 
32 
34 
 
99 
30 
31 
 
39 
34 
30 
 
43 
19 
19 
 
17 
22 
18 
0.531 
Cigarette smoking 
 Smoker 
 Ex-smoker 
 Non-smoker 
 
15 
31 
225 
 
9 
12 
22 
 
37 
67 
337 
 
21 
27 
33 
 
65 
102 
324 
 
37 
41 
32 
 
59 
48 
131 
 
33 
19 
13 
0.000 
 Cigarettes (units/day) 
 ≤10  
 ≥10 
 
12 
3 
 
12 
4 
 
28 
9 
 
27 
13 
 
37 
24 
 
36 
35 
 
26 
33 
 
25 
48 
0.007 
BMI classes 
 Undernutrition 
 Eutrophic 
 Overweight 
 Obesity 
 
0.002 
14 
166 
56 
23 
26  23  44  13  24  3  6 
21  245  31  262  33  115  15 
14  123  30  154  37  79  19 
18  34  27  42  33  28  22 
Notes: NCC = non-coffee consumers; N = number of subjects; % = percentage, BMI = body mass 
index (Kg/m
2). Sixty participants did not state their weight and/or height for BMI calculations.  
￿ P value obtained by Fisher exact test with significance at p < 0.05. 
 
Type-2  diabetes  and  family  antecedents  of  NCCD  in  relation  to  coffee  intake  are  presented  in  
Table 2. Coffee consumers of >100 mL/day reported more cases of cancer in their parents (Table 2). 
Table 2. Raw frequencies for diabetes and family non-communicable diseases according to 
coffee intake in the Federal District, Brazil, 2006–2009. 
 
Knowledge of diseases 
 
Coffee intake (mL per day) 
NCC  ≤100  100–400  >400 
P value 
b  N  %  N  %  N  %  N  % 
Subjects 
Diabetes mellitus 
Yes 
No 
7 
263 
13 
19 
16 
421 
30 
31 
17 
470 
31 
34 
14 
216 
26 
16 
0.24 
Parent´s antecedents
a                     
Hypertension 
(n = 1,317) 
Yes 
No 
126 
130 
17 
23 
223 
174 
30 
30 
260 
184 
35 
32 
132 
88 
18 
15 
0.062 Int. J. Environ. Res. Public Health 2011, 8                 
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Table 2. Cont. 
Dyslipidaemias 
(n = 1,127) 
Yes 
No 
76 
153 
18 
22 
129 
210 
30 
30 
149 
224 
35 
32 
75 
111 
17 
16 
0.349 
Diabetes mellitus 
(n = 1,332) 
Yes 
No 
39 
217 
16 
20 
73 
329 
28 
31 
103 
351 
39 
33 
45 
175 
17 
16 
0.187 
Cancer 
(n = 1,363) 
Yes 
No 
23 
240 
13 
20 
49 
365 
27 
31 
70 
392 
39 
33 
39 
185 
21 
16 
0.016 
Parkinson’s disease 
(n = 1,361) 
Yes 
No 
8 
252 
38 
19 
3 
406 
14 
30 
9 
455 
43 
34 
1 
222 
5 
17 
0.056 
Alzheimer’s disease 
(n = 1,361) 
Yes 
No 
5 
259 
17 
20 
8 
402 
26 
30 
9 
455 
31 
34 
8 
215 
26 
16 
0.538 
NCC  =  non-coffee  consumers;  N  =  number  of  subjects.  Individuals  who  did  not  state  their 
knowledge of diseases are not included in this table.  
a Family antecedents: YES = father and/or mother, NO = without disease.
  
b P value obtained by the Fisher exact test with significance at p < 0.05. 
 
Because  of  the  disproportionate  number  of  females  (more  than  statistically  present  in  the 
population) we made adjustments for sex as well as for age and years of education, as these variables 
were shown to be biased in our population [25]. Results from the models refer to weighted values and 
reflect a corrected proportion of each variable in the study; thus, describing overall prevalence ratio for 
the association of coffee intake and diabetes, controlling for confounders observed in Table 1.  
In univariate analysis, it was found that being single (PR = 1.08; p = 0.002), younger (PR = 0.99;  
p < 0.001), smoking (PR = 1.03; p = 0.006) and having a lower BMI (PR = 0.99; p = 0.008), had a 
higher prevalence of not having type-2 diabetes when compared to the proposed alternatives (Table 3).  
Table  3.  Hierarchical  regression  model  for  self-reported  type-2  diabetes  in  individuals 
from the Federal District, Brazil, 2006–2009.* 
Variable 
Unadjusted prevalence 
ratio (CI) 
P value  Adjusted prevalence 
ratio (CI) 
P value 
First level         
Marital status         
Bachelor  1.082 (1.028 to 1.138)  0.002  1.040 (0.996 to 1.086)  0.077 
Married  1.044 (0.987 to 1.104)  0.131  1.044 (0.992 to 1.098)  0.094 
Other  1 (referent)    1 (referent)   
 
Age (years) 
       
0.997 (0.995 to 0.998)  <0.001  0.997 (0.996 to 0.999)  <0.001 
Second level         
Diabetes 
antecedents
a 
       
Yes  1 (referent)    1 (referent)   
No  1.033 (0.997 to 1.070)  0.073  1.010 (0.976 to 1.045)  0.582 
Dyslipidaemias 
antecedents
b 
       
Yes  1 (referent)    1 (referent)   
No  1.023 (0.997 to 1.050)  0.078  1.010 (0.985 to 1.034)  0.435 Int. J. Environ. Res. Public Health 2011, 8                 
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Table 3. Cont. 
Third level         
Smoking         
Smoker  1.026 (1.007 to 1.046)  0.006  1.016 (0.995 to 1.039)  0.136 
Ex-smoker  1.003 (0.975 to 1.032)  0.829  1.032 (0.997 to 1.068)  0.071 
Non-smoker  1 (referent)    1 (referent)   
Supplementation
c         
Yes  1.015 (0.993 to 1.037)  0.193  1.027 (1.001 to 1.053)  0.037 
No  1 (referent)    1 (referent)   
         
BMI (kg/m
2)  0.993 (0.988 to 0.998)  0.008  0.996 (0.992 to 1.00)  0.113 
Fourth level         
Coffee intake         
≤100 mL  1 (referent)    1 (referent)   
101–400 mL  1.014 (0.989 to 1.039)  0.283  1.027 (1.001 to 1.053)  0.039 
>400 mL  0.982 (0.945 to 1.021)  0.368  1.010 (0.967 to 1.054)  0.659 
* Type-2 diabetes was modelled with the binary response of higher prevalence–96% of ‘no’ respondents. 
CI = confidence interval; BMI = body mass index (Kg/m
2). 95% confidence interval.  
a Diabetes antecedents: parents of the interviewed subjects with type-2 diabetes diagnosis.  
b  Antecedents  of  dyslipidaemias:  parents  of  the  interviewed  subjects  with  diagnosis  of 
hypercholesterolaemia and/or hypertriglyceridaemia.  
c Supplementation: user or non-user of multivitamins and/or polyminerals.  
Model was run after sample weighting for sex, age and years of study according to the year 2000 
Brazilian census. Significant when P value was <0.05. 
 
In the multivariate analyses after adjusting confounding variables (Table 3): younger (PR = 0.99;  
p < 0.001), use of multivitamins and/or polyminerals (PR = 1.03; p = 0.037) and moderate coffee 
intake (101 to 400 mL/day) (PR = 1.03; p = 0.039) had a higher prevalence of not having diabetes 
mellitus compared to their referent categories. In other words, moderate coffee drinkers (100 to 400 
mL/day) had an almost 3% higher prevalence of not having diabetes mellitus than those drinking ≤100 
mL/day. However, for high coffee consumers (>400 mL/day), the prevalence of not having diabetes 
mellitus was not statistically different from those who consume less than 100 mL/day. 
One particular coffee brand was used by 80% of the interviewed participants. Coffee preparation 
was mainly filtered (82%), while 5.2% preferred to consume instant coffee and 2.8% consumed either 
filtered or instant coffee. Additionally, we measured the content of chlorogenic acids (CGA’s) and 
caffeine in the most reported coffee brand, using an HPLC method by a respected coffee laboratory in 
Brazil. On a 100 g powder basis there were 837 mg of CGA’s and 1,461 mg of caffeine. Coffee 
dilution recommended and widely used in Brazil is 10 g of coffee powder to 100 mL of hot water [26]. 
4. Discussion 
This  study  suggests  that  moderate  coffee  consumption  is  protective  against  type-2  diabetes 
occurrence  in  urban  Brazilians  living  in  the  Federal  District.  Because  the  association  was  only 
significant at intermediate level of coffee intake and not at lower or higher levels, it indicates other Int. J. Environ. Res. Public Health 2011, 8                 
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intervening variables. Nevertheless, our findings are in agreement with other cross-sectional studies 
done in Greece [18], Sweden [14,27], Spain [28], the Netherlands [16,29], Denmark [30],
 Finland [31]
 
and Japan [32]. In these European countries coffee is most likely consumed in instant form (or soluble) 
and as an infusion (or paper filtered). It should be noted that not only the method of coffee preparation 
but also the amount of coffee consumed and attendant components are measured and modelled in ways 
that render studies complex to compare. A comprehensive comparison of parameters in cross-sectional 
studies is shown in Table 4. It is worth mentioning that this study is consistent with the bulk of high 
quality epidemiology done with prospective studies [2,17]. 
Notably, in our study, demographic and environmental variables most likely to interact with coffee 
consumption were age, years of schooling, sedentarism, cigarette smoking, and nutritional status. In 
this regard, van Dam and Feskens [9] observed high coffee intake among those with lower schooling 
levels and among younger subjects [16]. However, regarding cigarette smoking several studies have 
also shown a significant and positive association with coffee intake [9,11,15,16]. Regarding physical 
activity, Salvaggio et al. [33], found a positive relation between coffee intake and physical activity. 
This was a descriptive study designed to evaluate self-reported coffee consumption, life style and 
prevalence of type-2 diabetes. There are a number of potential limitations that should be considered 
when interpreting the results of this study. The research was conducted by telephone interview, which 
precluded individuals with no access to telephone lines. The sampling protocol adequately represented 
individuals from all regions of the Federal District but cannot be taken as representative of the entire 
population. It is also known that a cross-sectional study involves attendant limitations. The causality or 
temporality of the relationships between coffee intake and diabetes cannot be determined. 
We  are  aware  that  in  this  type  of  study  we  cannot  properly  address  the  required  information 
concerning other confounding factors associated with type-2 diabetes, nor can we deal with variables 
directly  related  to  coffee  preparations  and  consumption.  Nevertheless,  compared  to  published  
cross-sectional  studies,  our  data  add  a  unique  characteristic  from  a  developing  country  with  a 
nutritional lifestyle that is quite different from that of developed countries (Table 4). Therefore, this 
study permits health scientists to contextualize a persistent  association  of coffee consumption and 
prevalence of type-2 diabetes. 
It should be noted that our sample size, comparatively, is among the 50% largest of the published 
studies (Table 4). Although there are several metabolic active substances in the coffee beverage that 
might  interfere  with  pathophysiology  of  type-2  diabetes,  so  far  caffeine  is  the  most  studied  and 
pharmacologically described one. In this regard, our study is one of the few that adds information 
pertaining to caffeine intake per se. Furthermore, the amount of sugar taken with coffee may vary with 
the  quality  of  the  product  consumed  but  also  with  the  habitual  ‘sweet  tooth’  that  is  culturally 
developed. The fact that we found a protective effect against type-2 diabetes occurrence in moderate 
coffee consumers may reflect a threshold related to added sugar in high coffee consumers (>400 mL).  
Excessive sugar added to beverages may increase the risk of NCCD [34,35]. However, there are no 
studies in Brazil that quantify the amount of sugar added to coffee. In a clinical trial Louie et al. [36] 
showed that only sweetened black coffee significantly reduces postprandial glycaemia when compared 
with either black coffee or hot water 1 hour prior to a high carbohydrate meal. In contrast, Sartorelli  
et al. [37] showed that addition of sugar to coffee had no difference in the protection against the risk of 
diabetes among French women. Int. J. Environ. Res. Public Health 2011, 8                 
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Therefore  there  are  still  paradoxical  findings  from  clinical  and  observational  studies  involving 
sweetened coffee and the risk of diabetes. A limitation of the present study is that sugar added to 
coffee was not quantified. 
Multivariate methods are important tools because they allow determination of the relative roles of 
multiple factors. Hierarchical multivariate models go further and make it possible to include variables 
in the model at different levels of the causal chain with the sequential introduction of variables from 
the distal to the proximal level, following a prior conceptual model. The interpretation of conceptual 
models is complex and alternative explanations are often possible, depending on the order in which 
these  factors  are  defined  in  the  causal  chain  [38].  In  this  respect  it  should  be  noted  that  use  of 
nutritional supplements and moderate coffee intake are associated with protection for type-2 diabetes 
after controlling for first and second levels, and for first, second and third levels factors hierarchically 
in our model, respectively. Because vitamin C is known to be one of the most used supplements in the  
population [39] (in our study it was the most used—data not shown) and as vitamin C has antioxidant 
properties [40], the association of moderate coffee persists after controlling of this factor.  
Mainly as a result of the generation of compounds deriving from the Maillard reaction, the roasting 
process  leads  to  substantial  changes  in  the  chemical  composition  and  biological  activities  of  
coffee [41]. In addition to this, coffee consumption around the world varies greatly, thus causing an 
attendant variation in components as a result of bean-roasting and/or brewing technique [2]. In Brazil,  
medium-roast coffee is the most widely used [26]. A roasting time of 10 minutes (medium-dark roast) 
was  found  to  produce  coffee  with  optimal  oxygen  scavenging  and  chain  breaking  activities  
in  vitro  [42].  Del  Castillo  et  al.  [43]  confirmed  that  light  roast  or  medium  roast  coffee  has  a 
significantly  higher  antioxidant  activity  in  vitro  than  green  coffee.  This  difference  was  observed 
despite a 19% and 45% decrease in the chlorogenic acids (CGA) content in light and medium-roast 
coffee,  respectively;  this  implies  that  other  compounds  make  significant  contributions  to  the  total 
antioxidant activity of roasted coffee. Farah et al. [44] determined CGA content in different varieties 
of coffee. Total CGA content in regular green arabica samples was 5.1, 5.4, 6.4, and 5.6 g%, on a dry 
matter  basis  (dm),  for  Bourbon,  Sumatra  from  Mandelim,  Sumatra  from  Sulawesi,  and  Heirloom, 
respectively. The average levels of total CGA after 6, 7, and 8 minute of roasting were 3.4, 2.0, and  
1.0  g%  for  regular  coffee  and  3.3,  1.8,  and  0.9  g%  for  decaffeinated  coffee  (dm),  respectively. 
Information on coffee composition from cross-sectional studies is rare. In Table 4, we present the 
amount of caffeine and CGA recalculated for 100mL of coffee from the few available data. Compared 
to other studies, our sample drank coffee with medium CGA content and the highest caffeine content, 
which  may  partially  explain  the  absence  of  association  with  type-2  diabetes  for  high  coffee  
consumers [4]. Int. J. Environ. Res. Public Health 2011, 8                 
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Table 4. Description of cross-sectional studies on coffee intake and type-2 diabetes. 
 
 
Reference 
 
Country and 
Sample 
characteristics 
(n, sex, age) 
 
 
Model used and results 
presentation 
Observed results   
Cup 
volume 
(mL) 
 
Total 
CGA´s 
content 
(mg/ 
100 mL) 
 
Caffeine 
content 
(mg/ 
100 mL) 
0 or  
<1 cup 
1–2 
cups or 
≤2 cups 
3–4 
cups 
>4 
cups or 
5–6 
cups 
>7 cups 
Machado  
et al. (Present 
study) 
BRAZIL  
N = 1,440 
Both sexes 
18 to 89 year 
Hierarchical regression 
model and Poisson 
regression (PR for diabetes 
status)  
1.0  1.027 (2.7% self 
report of ‘no’ 
diabetes) 
1.010  120  84  146 
Panagiotakos 
et al.
[18 ] 
 
GREECE 
n = 937 
Both sexes 
65 to 100 year 
Multiple logistic regression 
analysis (multi-adjusted OR) 
1.0  0.47  1.05  150  NI  28 
Agardh  
et al. 
[14] 
SWEDEN 
N = 7,949 
Both sexes 
35 to 56 year 
Multiple logistic regression 
analysis (OR referred to as 
RR). 
Men: 1.0 
Women: 1.0 
0.52 
0.41 
0.36 0.28  150-
200 
NI  67 
Yamaji  
et al. 
[15] 
 
JAPAN 
N = 3,224 
Only males 
46 to 59 year 
Multiple logistic regression 
analysis  
1.0  0.8  0.7  0.7  150  NI  40 
Van Dam  
et al. 
[16] 
NETHERLANDS 
N = 1,312 
Both sexes 
50 to 74 year 
 
Adjusted differences in  
2-hour glucose 
concentrations according 
to categories of coffee 
consumption using analysis 
of covariance. 
Logistic regression analysis 
Baseline data: ≤2 
cups/day 
multivariate-
adjusted 2-hour 
post-load glucose 
concentrations 
were observed:  
-0.52 
mM 
  
-0.76 
mM 
 
  
-0.87  
mM 
 
  
125  100  NI Int. J. Environ. Res. Public Health 2011, 8                 
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Table 4. Cont. 
Van Dam  
et al. 
[ 29] 
NETHERLANDS 
N = 419 
Only males 
69 to 94 year 
 
Multivariate models 
 
Prevalence of glucose 
intolerance  
Multivariate-adjusted 
 
 
 
29% 
1.0 
 
 
 
21% 
0.63 
 
 
 
14% 
0.35 
NI  NI  NI 
Reference  Country and 
Sample 
characteristic
s (n, sex, age) 
Model used and results 
presentation 
Observed results  Cup 
volume 
(mL) 
Total 
CGA´s 
content 
(mg/ 
100 mL) 
Caffeine 
content 
(mg/ 
100 mL) 
Bidel 
[31] 
(Academic 
dissertation) 
FINLAND 
n = 2,956 
Both sexes 
45 to 64 year 
 
Multiple logistic regression 
analysis 
Coffee consumption as a continuous variable 
showed that an increment of one cup of coffee per 
day was associated with a 10% lower risk of 
impaired fasting glucose, an 8% lower risk of 
isolated impaired glucose tolerance, a 9% lower 
risk of impaired glucose regulation, and an 11% 
lower risk of hyperinsulinaemia if both men and 
women were combined. 
240  35-175  42 
Ärnlöv  
et al. 
[27] 
SWEDEN 
N = 936 
Only males 
50 to 88 year 
Multivariate regression 
models 
An increase of one cup of coffee per 
day was associated with 0.16-units higher insulin 
sensitivity (insulin sensitivity index was determined 
by hyperinsulinaemic euglycaemic clamp). 
150  NI  NI 
Soriguer  
et al. 
[28] 
SPAIN 
N = 1,226 
Both sexes 
Adults (age 
not informed) 
Multiple logistic regression 
analysis 
Persons who drank coffee at least once per day had 
a lower risk for diabetes mellitus and impaired 
glucose tolerance (odds ratio, 0.66 [95% CI, 0.48 to 
0.92]; P < 0.02) than persons who drank coffee only 
occasionally. 
NI  NI  NI 
Isogawa  
et al. 
[32] 
 
JAPAN 
N = 4,620 
Both sexes 
40 to 50 year 
NI  Coffee intake was inversely associated with the 
prevalence of fasting hyperglycaemia. 
Risk of having prevalent fasting hyperglycaemia: 
OR = 0.614 
NI  NI  NI 
Abbrevations: NI, not informed; PR, prevalence ratio; OR, odds ratio; RR, relative risk; CGA’s, chlorogenic acids. Int. J. Environ. Res. Public Health 2011, 8                 
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Overall, as summarized in Table 4, consistency of cross-sectional studies (like ours) from different 
countries underscores a biological mechanism associated with coffee composition. Among proposed 
components are minerals (magnesium) and phytochemicals (mainly chlorogenic acids) that per se or in 
combination could provide a unique antioxidant functionality that would benefit coffee drinkers [2,45]. 
Additionally, time of drinking coffee could also play a distinct role in glucose metabolism [37]. This 
adds a physiological component to the understanding of some benefits of coffee consumption. 
5. Conclusions  
These data complement the gradually growing body of information that provides evidence for the 
overall beneficial effects of coffee consumption in relation to type-2 diabetes. However, the biological 
effects of coffee constituents and other intervening constitutional and environmental variables deserve  
further investigation. 
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